Keita Mori

6.4k citations

221 papers · 3.6k indexed · h-index 33

Oncology top 1%
- Lung Cancer Research Studies 41
- Colorectal Cancer Treatments and Studies 31
- Cancer Immunotherapy and Biomarkers 20
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations 74
- Lung Cancer Diagnosis and Treatment 40
- Gastric Cancer Management and Outcomes 36
Hepatology top 5%
Gastroenterology top 2%
Geriatrics and Gerontology top 2%
Cancer Research
- Cancer Genomics and Diagnostics 16
Epidemiology
- Neuroendocrine Tumor Research Advances 15

Co-authors: Toshiaki Takahashi Hirotsugu Kenmotsu Tateaki Naito Haruyasu Murakami Akira Ono Masahiro Endo Kazushige Wakuda Nobuyuki Yamamoto
Cited by: Oncology Pulmonary and Respiratory Medicine Hepatology
Journals: Journal of Clinical Oncology (12 papers)SHILAP Revista de lepidopterología (3 papers)PLoS ONE (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Keita Mori

208 papers receiving 3.6k citations

Peers

Countries citing papers authored by Keita Mori

Since Specialization

Citations

This map shows the geographic impact of Keita Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keita Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keita Mori more than expected).

Fields of papers citing papers by Keita Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keita Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keita Mori. The network helps show where Keita Mori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Keita Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keita Mori Line = papers co-authored together Keita Mori links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of the Insulated‐Tip Knife on Procedure Time in Endoscopic Submucosal Dissection for Colorectal Neoplasms: A Single‐Center, Randomized Controlled Trial (NANO Study) Journal of Gastroenterology and Hepatology ·Sayo Ito,Kinichi Hotta,Kenichiro Imai,Yoshihiro Kishida,Kazunori Takada,Noboru Kawata,Masao Yoshida,Yoichi Yamamoto,Junya Sato,Hirotoshi Ishiwatari,Hiroyuki Matsubayashi,Keita Mori,Hiroyuki ONO	2025	0
2	An Estimation Formula for Resonance Frequency Using Sex and Height for Healthy Individuals and Patients with Incurable Cancers Applied Psychophysiology and Biofeedback ·Hideaki Hasuo,Keita Mori,Hiromichi Matsuoka,Hiroko Sakuma,Hideki Ishikawa	2023	0
3	A novel low‐power pure‐cut hot snare polypectomy for 10–14 mm colorectal adenomas: An ex vivo and a clinical prospective feasibility study (SHARP trial) Journal of Gastroenterology and Hepatology ·Kenichiro Imai,Kinichi Hotta,Sayo Ito,Yoshihiro Kishida,Kazunori Takada,Tetsuya Suwa,Hiroshi Ashizawa,Tatsunori Minamide,Yoichi Yamamoto,Masao Yoshida,Yuki Maeda,Noboru Kawata,Junya Sato,Hirotoshi Ishiwatari,Hiroyuki Matsubayashi,Takuma Oishi,Takashi Sugino,Keita Mori,Hiroyuki Ono	2023	3
4	Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non‐small cell lung cancer Cancer Reports ·Yukihiro Terada,Mitsuhiro Isaka,Akira Ono,Takuya Kawata,Masakuni Serizawa,Keita Mori,Koji Muramatsu,Kiyoshi Tone,Hirotsugu Kenmotsu,Keiichi Ohshima,Kenichi Urakami,Takeshi Nagashima,Masatoshi Kusuhara,Yasuto Akiyama,Takashi Sugino,Toshiaki Takahashi,Yasuhisa Ohde	2023	0
5	The Details of Inpatient Cancer Rehabilitation Provided by Designated Cancer Hospitals in Japan Palliative Care Research ·Takuya Fukushima,Tetsuya Tsuji,Jiro Nakano,Shun Ishii,Shinsuke Sugihara,Hiroshi Satō,Juichi Kawakami,Hitoshi Kagaya,Akira Tanuma,Ryuichi Sekine,Keita Mori,Sadamoto Zenda,Akira Kawai	2023	1
6	Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy Advances in Radiation Oncology ·Kosei Doshita,Yuya Tabuchi,Hirotsugu Kenmotsu,Shota Omori,Takanori Kawabata,Hiroaki Kodama,Naoya Nishioka,Eriko Miyawaki,Yuko Iida,Nobuaki Mamesaya,Haruki Kobayashi,Ryo Ko,Kazushige Wakuda,Akira Ono,Tateaki Naito,Haruyasu Murakami,Keita Mori,Hideyuki Harada,Takeshi Kaneko,Toshiaki Takahashi	2022	4
7	Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer Cancer Medicine ·Taichi Miyawaki,Hirotsugu Kenmotsu,Kosei Doshita,Hiroaki Kodama,Naoya Nishioka,Yuko Iida,Eriko Miyawaki,Nobuaki Mamesaya,Haruki Kobayashi,Shota Omori,Ryo Ko,Kazushige Wakuda,Akira Ono,Tateaki Naito,Haruyasu Murakami,Keita Mori,Hideyuki Harada,Masahiro Endo,Kazuhisa Takahashi,Toshiaki Takahashi	2022	4
8	Artificial Intelligence–Powered Prediction of ALK Gene Rearrangement in Patients With Non–Small-Cell Lung Cancer JCO Clinical Cancer Informatics ·Yukihiro Terada,T. Takahashi,Takamitsu Hayakawa,Akira Ono,Takuya Kawata,Mitsuhiro Isaka,Koji Muramatsu,Kiyoshi Tone,Hiroaki Kodama,Toru Imai,Akifumi Notsu,Keita Mori,Yasuhisa Ohde,Takashi Nakajima,Takashi Sugino,Toshiaki Takahashi	2022	4
9	Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer (MAPLE) to communicate ageing-related concerns: J-SUPPORT 2101 study protocol for a multicentre, parallel group, randomised controlled trial BMJ Open ·Ayumu Matsuoka,Maiko Fujimori,Narikazu Boku,Atsuo Takashima,Takuji Okusaka,Keita Mori,Tatsuo Akechi,Taichi Shimazu,Ayumi Okizaki,Tempei Miyaji,Yoshiyuki Majima,Fumio Nagashima,Yosuke Uchitomi	2022	2
10	A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082) International Journal of Gynecological Cancer ·Akiko Furusawa,Munetaka Takekuma,Keita Mori,Tomoka Usami,Eiji Kondo,Shin Nishio,Koji Nishino,Yuichiro Miyamoto,Ryoichi Yoshimura,Miho Watanabe,Mikio Mikami,Takayuki Enomoto	2021	14
11	Impact of Physical Inactivity on the Risk of Disability and Hospitalization in Older Patients with Advanced Lung Cancer Journal of Multidisciplinary Healthcare ·Yusuke Yonenaga,Tateaki Naito,Taro Okayama,Midori Kitagawa,Noriko Mitsuhashi,Takeshi Ishii,Hiroshi Fuseya,Toshimi Inano,Ayumu Morikawa,Miwa Sugiyama,Keita Mori,Akifumi Notsu,Takanori Kawabata,Akira Ono,Hirotsugu Kenmotsu,Haruyasu Murakami,Akira Tanuma,Toshiaki Takahashi	2021	7
12	LBA44 Primary results of a randomized phase II study of osimertinib plus bevacizumab versus osimertinib monotherapy for untreated patients with non-squamous non-small cell lung cancer harboring EGFR mutations: WJOG9717L study Annals of Oncology ·Hirotsugu Kenmotsu,Kazushige Wakuda,Keita Mori,T. Kato,Shunichi Sugawara,Keisuke Kirita,Isamu Okamoto,Koichi Azuma,Kazumi Nishino,Shunsuke Teraoka,Ryo Koyama,Ken Masuda,Hidetoshi Hayashi,Ryo Toyozawa,Satoru Miura,Yuki Sato,Kazuhiko Nakagawa,Nobuyuki Yamamoto,Toshiaki Takahashi	2021	11
13	Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software Anticancer Research ·Haruo Miyata,Yasuto Akiyama,Akira Iizuka,Ryota Kondou,Chie Maeda,Akari Kanematsu,Kyoko Watanabe,Tadashi Ashizawa,Takeshi Nagashima,Kenichi Urakami,Keiichi Ohshima,Takuya Kawata,Koji Muramatsu,Akio Shiomi,Masanori Terashima,Takashi Sugino,Akifumi Notsu,Keita Mori,Ken Yamaguchi	2021	3
14	Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy Cancer Science ·Taichi Miyawaki,Kazushige Wakuda,Hirotsugu Kenmotsu,Eriko Miyawaki,Nobuaki Mamesaya,Haruki Kobayashi,Shota Omori,Akira Ono,Tateaki Naito,Haruyasu Murakami,Akifumi Notsu,Keita Mori,Hideyuki Harada,Masahiro Endo,Yasuhisa Ohde,Kazuhisa Takahashi,Toshiaki Takahashi	2020	8
15	Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer Cancer Medicine ·Naoya Nishioka,Tateaki Naito,Akifumi Notsu,Keita Mori,Hiroaki Kodama,Eriko Miyawaki,Taichi Miyawaki,Nobuaki Mamesaya,Haruki Kobayashi,Shota Omori,Kazushige Wakuda,Akira Ono,Hirotsugu Kenmotsu,Haruyasu Murakami,Koichi Takayama,Toshiaki Takahashi	2020	30
16	Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan Pancreas ·Akiko Todaka,Nobumasa Mizuno,Masato Ozaka,Hideki Ueno,Satoshi Kobayashi,Kazuhiro Uesugi,Noritoshi Kobayashi,Hideyuki Hayashi,Kentaro Sudo,Naohiro Okano,Yosuke Horita,Keiko Kamei,Seigo Yukisawa,Shoji Nakamori,Yutaka Yachi,Toshiyuki Henmi,Marina Kobayashi,Narikazu Boku,Keita Mori,Akira Fukutomi	2018	13
17	Continuous paravertebral block using a thoracoscopic catheter-insertion technique for postoperative pain after thoracotomy: a retrospective case-control study Journal of Cardiothoracic Surgery ·Yoshikane Yamauchi,Mitsuhiro Isaka,Kamon Ando,Keita Mori,Hideaki Kojima,Tomohiro Maniwa,Shoji Takahashi,Eiji Ando,Yasuhisa Ohde	2017	18
18	169P Serum CA19-9 response is an early predictive marker for the efficacy of regorafenib in refractory metastatic colorectal cancer Annals of Oncology ·A. Komori,Hiroya Taniguchi,Yosuke Kito,Satoshi Hamauchi,Toshiki Masuishi,Hiroko Hasegawa,Seiichiro Mitani,Yukiya Narita,Shigenori Kadowaki,Takashi Ura,Masashi Ando,Keita Mori,Hirofumi Yasui,Kei Muro,Kentaro Yamazaki	2015	0
19	Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy Gastric Cancer ·Hiroyuki Tabuse,Hiroya Kashiwagi,Satoshi Hamauchi,Takahiro Tsushima,Akiko Todaka,Tomoya Yokota,Nozomu Machida,Kentaro Yamazaki,Akira Fukutomi,Yusuke Onozawa,Keita Mori,Narikazu Boku,Masao Ichinose,Hirofumi Yasui	2015	5
20	Differences in the efficacy of S‐1 monotherapy according to histological type in pretreated patients with advanced non‐small cell lung cancer Thoracic Cancer ·Yasushi Hisamatsu,Haruyasu Murakami,Hiroaki Akamatsu,Madoka Kimura,Keita Mori,Hisao Imai,Akira Ono,Takehito Shukuya,Tetsuhiko Taira,Hirotsugu Kenmotsu,Tateaki Naito,Masahiro Endo,Takashi Nakajima,Toshiaki Takahashi,Nobuyuki Yamamoto	2013	1

About Keita Mori

Keita Mori is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 221 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Research Studies (41 papers), Lung Cancer Diagnosis and Treatment (40 papers), Gastric Cancer Management and Outcomes (36 papers), Colorectal Cancer Treatments and Studies (31 papers), Cancer Immunotherapy and Biomarkers (20 papers), Cancer Genomics and Diagnostics (16 papers) and Neuroendocrine Tumor Research Advances (15 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Hepatology (268 citations). Keita Mori has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshiaki Takahashi, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Akira Ono, Masahiro Endo, Kazushige Wakuda, Nobuyuki Yamamoto, Katsuhiko Uesaka and Tetsuhiko Taira. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact